Standard Biotools (LAB) Current Assets (2010 - 2026)

Standard Biotools (LAB) has 17 years of Current Assets data on file, last reported at $521.5 million in Q1 2026.

• Quarterly Current Assets rose 51.58% year-over-year to $521.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $521.5 million (up 51.58% YoY) and the FY2025 annual result came in at $454.3 million, up 20.85% from the prior year.
• Current Assets improved to $521.5 million in Q1 2026 per LAB's latest filing, from $454.3 million in the prior quarter.
• Across five years, Current Assets topped out at $547.6 million in Q1 2024 and bottomed at $73.2 million in Q1 2022.
• The 5-year median for Current Assets is $344.0 million (2025), against an average of $330.8 million.
• The widest annual swing landed in 2022, when Current Assets jumped 220.79%; it then plunged 37.17% in 2025.
• Tracing LAB's Current Assets over 5 years: stood at $208.8 million in 2022, then dropped by 24.23% to $158.2 million in 2023, then surged by 137.58% to $375.9 million in 2024, then rose by 20.85% to $454.3 million in 2025, then advanced by 14.79% to $521.5 million in 2026.
• Per Business Quant, the three latest LAB Current Assets figures stand at $521.5 million (Q1 2026), $454.3 million (Q4 2025), and $472.4 million (Q3 2025).

Peer Comparison